Drugs / MTRX1011A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00718588 | Jul 2008 → Dec 2009 | rheumatoid arthritis | Genentech, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTRX1011A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00718588 ↗ |
| Route | Intravenous | “Subcutaneous and intravenous single and repeating dose” NCT00718588 ↗ |
| Route | Subcutaneous | “Subcutaneous and intravenous single and repeating dose” NCT00718588 ↗ |